Irinotecan | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Irinotecan
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Irinotecan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 29 USDMF, 13 CEP/COS, 10 JDMF, 7 EU WC, 12 KDMF, 12 NDC API, 37 Listed Suppliers, $ API Reference Price

69 API Suppliers
29 USDMF
13 CEP/COS
10 JDMF
7 EU WC
12 KDMF
12 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

483 Drugs in Development

483 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

219 FDF Dossiers, 65 FDA Orange Book, 93 Europe, 8 Canada, 14 Australia, 17 South Africa, 22 Listed Dossiers

219 FDF Dossiers
65 FDA Orange Book
93 Europe
8 Canada
14 Australia
17 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML)
INJECTABLE;INJECTION - 300MG/15ML (20MG/ML)
INJECTABLE;INJECTION - 40MG/2ML (20MG/ML)
INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 3 Actylis, 1 BioSpectra, 4 Nippon Fine Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

1 Rochem International Inc
2 SPI Pharma
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Shanghai Minbiotech
2 Kirsch Pharma
3 Actylis
1 BioSpectra
4 Nippon Fine Chemical
11 Roquette
1 Shijiazhuang Huaxu Pharmaceutical
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 9 Parenteral, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Co-Processed Excipients, 2 Chewable & Orodispersible Aids, 2 Solubilizers, 2 Topical, 1 Soft Gelatin, 1 Direct Compression, 1 Thickeners and Stabilizers, 1 Dry Powder Inhalation

9 Film Formers & Plasticizers
9 Parenteral
4 Fillers, Diluents & Binders
4 Taste Masking
4 Coating Systems & Additives
3 Surfactant & Foaming Agents
3 Emulsifying Agents
2 Co-Processed Excipients
2 Chewable & Orodispersible Aids
2 Solubilizers
2 Topical
1 Soft Gelatin
1 Direct Compression
1 Thickeners and Stabilizers
1 Dry Powder Inhalation

DIGITAL CONTENT

64 News #PharmaBuzz

64 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 66 Regulatory FDF Prices, 8 Annual Reports

11 US Medicaid Prescriptions
66 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

10 APIs, 9 FDF Dossiers

10 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 2 Health Canada Patents

22 US Patents
2 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

15 Others

15 Others

$ API Ref.Price (USD/KG) : 22,283 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Pfizer Canada Inc.

filter Patent Reset all filters

2 All

01 12202531

02 12294031

filter Product Reset all filters

2 All

01 2Irinotecan Hydrochloride

filter Dosage Reset all filters

2 All

01 2Liquid

filter Exp Date Reset all filters

2 All

01 12015-10-11

02 12018-07-27

Product Main Page

01

Pfizer Canada Inc.

Irinotecan Hydrochloride

ChemOutsourcing

Not Confirmed

Pfizer Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-10-11

Date Granted : 2005-05-03

Irinotecan Hydrochloride

Brand Name : CAMPTOSAR

Patent Number : 2202531

Filing Date : 1995-10-11

Strength per Unit : 20 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Injectable

Patent Expiration Date : 2015-10-11

Date Granted : 2005-05-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Canada Inc.

Irinotecan Hydrochloride

ChemOutsourcing

Not Confirmed

Pfizer Canada Inc.

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-27

Date Granted : 2005-01-18

Irinotecan Hydrochloride

Brand Name : CAMPTOSAR

Patent Number : 2294031

Filing Date : 1998-07-27

Strength per Unit : 20 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Injectable

Patent Expiration Date : 2018-07-27

Date Granted : 2005-01-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!